Chemotherapy-Induced Nausea and Vomiting: Information for your patients at emend.com
Merck
Patient Symptom Tracker

Patient Symptom Tracker

Tracking the symptoms of CINV while your patients are receiving chemotherapy is an important step in prevention. Download the scale below and give it to your patients. They can fill it in after each chemotherapy treatment and discuss the results with you.

Download Patient Symptom Tracker
PDF [PDF: 360 KB, 1 page]

Patient Brochure

Patient Brochure

Understanding the effects of chemotherapy is an important step in prevention. Print this brochure and give it to your patients. They can read about why chemo induces nausea and vomiting, determine their own risk of CINV, and learn about treatment options.

Download Patient Brochure
PDF [PDF: 1.00 MB, 6 pages]

Patient Brochure

MASCC Antiemesis Tool

MASCC, the Multinational Association of Supportive Care in Cancer, has developed the MASCC Antiemesis Tool (MAT). It is an easy-to-use and easy-to-evaluate tool meant to assist patients and oncology professionals in communicating accurately about the prevention and control of nausea and vomiting that may occur with chemotherapy.

Download MASCC Antiemesis Tool

To view PDF documents, you will need the free Adobe Acrobat Reader program.

Download Adobe Acrobat Reader

For information about Merck products or services, please call 866-448-7590. The Merck National Service Center will be pleased to assist you Monday through Friday from 8 AM to 7 PM ET.

Important Safety Information

EMEND and EMEND for Injection, in combination with other antiemetic agents, are indicated in adults for prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy, including high-dose cisplatin.

EMEND and EMEND for Injection have not been studied for treatment of established nausea and vomiting. Chronic continuous administration of EMEND or EMEND for Injection is not recommended.

Selected Important Safety Information

Before prescribing EMEND or EMEND for Injection, please read the Prescribing Information. The Patient Information also is available.

The information on this site is intended for health care professionals in the United States and is not intended for the general public.

I am a health care professional

I am not a health care professional